Symbols

QSI

Quantum-Si·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 2

Bearish Engulfing

Ample Liquidity

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About QSI

Quantum-Si Incorporated

A life sciences company that develops access to the proteome with single-molecule analysis and democratizing to researchers & clinicians

Industry

Biological Technology

Established Date

06/24/2013

Listing Date

11/13/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

138

Fiscal Year Ends

12-31

Website

www.quantum-si.com

Security Type

Common stock

Office address

29 Business Park Drive, Branford, Connecticut 06405

Business

Introduction

Quantum-Si Incorporated was originally incorporated under the laws of the State of Delaware on June 24, 2013. The company is a life sciences company focused on proteomics research, developing a proprietary platform for next-generation protein sequencing. Its product line includes Platinum series instruments, analysis software and kits, and is developing the next-generation platform Proteus.

Company Financials

EPS

QSI has released its 2025 Q4 earnings. EPS was reported at -0.08, versus the expected -0.12, beating expectations. The chart below visualizes how QSI has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

QSI has released its 2025 Q4 earnings report, with revenue of 451.00K, reflecting a YoY change of -62.16%, and net profit of -17.61M, showing a YoY change of 46.83%. The Sankey diagram below clearly presents QSI's revenue sources and cost distribution.